Cara Therapeutics | CARA - Trade Creditors


Cara Therapeutics reported $4.62M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 16.33M 28.24M Sep/2026
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Cara Therapeutics USD 4.62M 1.4M Mar/2026
Cassava Sciences USD 39.29M 102K Jun/2026
Chugai Pharma JPY 78.17B 82.53B Sep/2026
Cipla INR 32.66B 361.1M Sep/2026
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.15M 371K Jun/2026
CSL USD 3.17B 290M Dec/2025
Grifols EUR 987.75M 47.87M Dec/2025
Halozyme Therapeutics USD 33.55M 9.94M Sep/2026
J&J USD 9.32B 94M Sep/2026
Neurocrine Biosciences USD 754.1M 612.1M Sep/2026
Pacira USD 17.5M 4K Sep/2026
Pfizer USD 4.07B 511M Sep/2026
RedHill Biopharma USD 584K 147K Jun/2026
Supernus Pharmaceuticals USD 8.52M 2.92M Sep/2026
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024